摘要
目的:观察研究美沙拉嗪联合酪酸梭菌活菌片对溃疡性肠炎的临床治疗效果以及对C反应蛋白的影响。方法:从我院收治入院的溃疡性结肠炎患者中抽取60例随机分为观察组与对照组,观察组患者使用美沙拉嗪与酪酸梭菌活菌片进行联合治疗,对照组单独使用美沙拉嗪进行治疗,对比两组患者的临床疗效、C反应蛋白及复发率。结果:观察组患者治疗总有效率明显高于对照组,治疗后C-反应蛋白活性、复发率均明显低于对照组,差异有统计学意义(P<0.05)。结论:对溃疡性结肠炎患者使用美沙拉嗪与酪酸梭菌活菌片联合治疗,能够有效缓解患者的临床症状,具有更为理想的临床疗效和更低的复发率。
Objective：To observe the clinical effect of mesalazine combined with Clostridium butyricum tablets in the treatment of colitis gravis and the influence of C reactive protein.Methods：60 reported cases of colitis gravis were collected and analyzed.All those patients were randomly divided into two teams：observation group and control group.In control group,those patients use mesalazine,while patients in observation group were given Clostridium butyricum tablets on the basis of mesalazine.The clinical effect,activity of C reactive protein and recurrence rate were compared between two teams.Results：After the treatment,the total effective rate of observation group was significantly higher than control group;meanwhile,the adverse reaction rate and recurrence rate were significantly lower than control group（P〈0.05）.Conclusion：Mesalazine combined with Clostridium butyricum tablets is effective to improve the clinical symptoms in the treatment of colitis gravis and it is tended to lower recurrence rate.
出处
《中国医药导刊》
2013年第6期1004-1005,共2页
Chinese Journal of Medicinal Guide
